Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory

被引：0
作者：
Hristova, Mariyana [1 ]
机构：
[1] Med Ctr Varna, Div Endocrinol, Varna, Bulgaria
来源：
MEDICAL HYPOTHESES | 2017年 / 102卷
关键词：
TYPE-2; DIABETES-MELLITUS; METABOLIC SYNDROME; SGLT2; INHIBITORS; BLOOD-PRESSURE; KIDNEY-DISEASE; HYPOTHESIS; OUTCOMES; DAPAGLIFLOZIN; REABSORPTION; METAANALYSIS;
D O I：
10.1016/j.mehy.2017.02.021
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：61 / 64
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis
    Shiau, Chu-Hsuan
    Tsau, Li-Yun
    Kao, Chih-Chin
    Peng, Yu-Ching
    Bai, Chyi-Huey
    Wu, Jeng-Cheng
    Hou, Wen-Hsuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (04) : 1359 - 1381
  • [22] Effect of sodium-glucose cotransporter-2 inhibitors on renal handling of electrolytes
    Meena, Priti
    Bhargava, Vinant
    Bhalla, Anil
    Rana, Devinder
    Mantri, Alok
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1154) : 819 - 824
  • [23] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
    Profili, Nicia I.
    Castelli, Roberto
    Manetti, Roberto
    Sircana, Marta C.
    Pagni, Michela
    Sechi, Gemma Lisa
    Gidaro, Antonio
    Cossu, Costantino
    Bella, Francesco
    Delitala, Alessandro P.
    BIOMEDICINES, 2025, 13 (03)
  • [24] Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
    Shakour, Neda
    Karami, Shima
    Iranshahi, Mehrdad
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [25] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms
    Kashihara, Naoki
    Kidokoro, Kengo
    Kanda, Eiichiro
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (01) : 112 - 118
  • [26] Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
    Dubrofsky, Lisa
    Srivastava, Anand
    Cherney, David Z.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2020, 7
  • [27] Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
    Nelson, Adam J.
    Harrington, Josephine L.
    Kolkailah, Ahmed A.
    Pagidipati, Neha J.
    McGuire, Darren K.
    HEART FAILURE CLINICS, 2022, 18 (04) : 597 - 607
  • [28] Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications
    Bardia, Amit
    Wai, Mabel
    Fontes, Manuel L.
    CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (01) : 80 - 85
  • [29] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy
    Byer, Stefano H.
    Sivamurugan, Aravinthasamy
    Grewal, Udhayvir S.
    Fradley, Michael G.
    Dominic, Paari
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 243 : 15 - 18
  • [30] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
12345